Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3 - PubMed
- ️Fri Jan 01 1999
Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3
P Sassone-Corsi et al. Science. 1999.
Abstract
During the immediate-early response of mammalian cells to mitogens, histone H3 is rapidly and transiently phosphorylated by one or more unidentified kinases. Rsk-2, a member of the pp90rsk family of kinases implicated in growth control, was required for epidermal growth factor (EGF)-stimulated phosphorylation of H3. RSK-2 mutations in humans are linked to Coffin-Lowry syndrome (CLS). Fibroblasts derived from a CLS patient failed to exhibit EGF-stimulated phosphorylation of H3, although H3 was phosphorylated during mitosis. Introduction of the wild-type RSK-2 gene restored EGF-stimulated phosphorylation of H3 in CLS cells. In addition, disruption of the RSK-2 gene by homologous recombination in murine embryonic stem cells abolished EGF-stimulated phosphorylation of H3. H3 appears to be a direct or indirect target of Rsk-2, suggesting that chromatin remodeling might contribute to mitogen-activated protein kinase-regulated gene expression.
Similar articles
-
Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.
Mérienne K, Jacquot S, Zeniou M, Pannetier S, Sassone-Corsi P, Hanauer A. Mérienne K, et al. Oncogene. 2000 Aug 31;19(37):4221-9. doi: 10.1038/sj.onc.1203712. Oncogene. 2000. PMID: 10980595
-
Chadee DN, Hendzel MJ, Tylipski CP, Allis CD, Bazett-Jones DP, Wright JA, Davie JR. Chadee DN, et al. J Biol Chem. 1999 Aug 27;274(35):24914-20. doi: 10.1074/jbc.274.35.24914. J Biol Chem. 1999. PMID: 10455166
-
Ultraviolet B-induced phosphorylation of histone H3 at serine 28 is mediated by MSK1.
Zhong S, Jansen C, She QB, Goto H, Inagaki M, Bode AM, Ma WY, Dong Z. Zhong S, et al. J Biol Chem. 2001 Aug 31;276(35):33213-9. doi: 10.1074/jbc.M103973200. Epub 2001 Jul 5. J Biol Chem. 2001. PMID: 11441012
-
RSK in tumorigenesis: connections to steroid signaling.
Eisinger-Mathason TS, Andrade J, Lannigan DA. Eisinger-Mathason TS, et al. Steroids. 2010 Mar;75(3):191-202. doi: 10.1016/j.steroids.2009.12.010. Epub 2010 Jan 4. Steroids. 2010. PMID: 20045011 Free PMC article. Review.
Cited by
-
RSK2 as a key regulator in human skin cancer.
Cho YY, Lee MH, Lee CJ, Yao K, Lee HS, Bode AM, Dong Z. Cho YY, et al. Carcinogenesis. 2012 Dec;33(12):2529-37. doi: 10.1093/carcin/bgs271. Epub 2012 Aug 23. Carcinogenesis. 2012. PMID: 22918890 Free PMC article.
-
Ivaldi MS, Karam CS, Corces VG. Ivaldi MS, et al. Genes Dev. 2007 Nov 1;21(21):2818-31. doi: 10.1101/gad.1604007. Epub 2007 Oct 17. Genes Dev. 2007. PMID: 17942706 Free PMC article.
-
Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.
Malakhova M, Kurinov I, Liu K, Zheng D, D'Angelo I, Shim JH, Steinman V, Bode AM, Dong Z. Malakhova M, et al. PLoS One. 2009 Nov 30;4(11):e8044. doi: 10.1371/journal.pone.0008044. PLoS One. 2009. PMID: 19956600 Free PMC article.
-
Cascade of distinct histone modifications during collagenase gene activation.
Martens JH, Verlaan M, Kalkhoven E, Zantema A. Martens JH, et al. Mol Cell Biol. 2003 Mar;23(5):1808-16. doi: 10.1128/MCB.23.5.1808-1816.2003. Mol Cell Biol. 2003. PMID: 12588998 Free PMC article.
-
A regulatory mechanism for RSK2 NH(2)-terminal kinase activity.
Cho YY, Yao K, Pugliese A, Malakhova ML, Bode AM, Dong Z. Cho YY, et al. Cancer Res. 2009 May 15;69(10):4398-406. doi: 10.1158/0008-5472.CAN-08-4959. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435896 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases